Mereo BioPharma Group PLC ADR share price logo

Mereo BioPharma Group PLC ADR

NASDAQ: MREO

Small Cap

$0.30

(+-1.31%)

as on

Mereo BioPharma Group PLC ADR Stock Performance

as on June 10, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $0.29
    $0.31
    downward going graph

    3.33%

    Downside

    3.33%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.20
    $3.05
    downward going graph

    33.33%

    Downside

    916.67%

    Upside

    downward going graph

Mereo BioPharma Group PLC ADR share price movements today

Previous Close
$0.30
Open
$0.29
Volume
2.2M
Day's Low - High
$0.29 - $0.31
52 Week Low - High
$0.20 - $3.05

Mereo BioPharma Group PLC ADR Historical Returns

1 Month Return
+ 22.2 %
3 Month Return
-22.11 %
1 Year Return
-88.49 %
3 Year Return
-77.07 %
5 Year Return
-90.44 %

Mereo BioPharma Group PLC ADR Stock Fundamentals & Key Indicators

Check Mereo BioPharma Group PLC ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$50.0M

EPS (TTM)

-0.0282

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-35.6M

Revenue (TTM)

500.0K

Profit Margin

0.00%

Return On Equity TTM

-75.87%

Mereo BioPharma Group PLC ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mereo BioPharma Group PLC ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Mereo BioPharma Group PLC ADR image
Mereo BioPharma Group PLC ADR
BUY$50.0M-90.44%NA0.00%NA
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.5B85.6%76.3312.55%NA
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$113.4B107.42%26.5235.51%NA
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$66.6B17.15%15.529.65%0.5700000000000001%

Stock Returns calculator for Mereo BioPharma Group PLC ADR Stock including INR - Dollar returns

The Mereo BioPharma Group PLC ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Mereo BioPharma Group PLC ADR investment value today

Current value as on today

₹12,599

Returns

-₹87,401

(-87.4%)

Returns from Mereo BioPharma Group PLC ADR Stock

-₹88,679 (-88.68%)

Dollar Impact

₹1,278 (+1.28%)

Analyst Recommendation on Mereo BioPharma Group PLC ADR Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Mereo BioPharma Group PLC ADR. Average target price of $1.72

Mereo BioPharma Group PLC ADR Share Price Target

Get share price movements and forecasts by analysts on Mereo BioPharma Group PLC ADR.

What analysts predicted

82.56%UPSIDE

Target Price

$1.72

Current Price

$0.3

Analyzed by

10 Analysts

Target

$1.72

Mereo BioPharma Group PLC ADR target price $1.72, a slight upside of 82.56% compared to current price of $0.3. According to 10 analysts rating.

Indian Investors' Interest in Mereo BioPharma Group PLC ADR Stock

Search interest for Mereo BioPharma Group PLC ADR Stock has increased by 202% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:202% versus previous 30 day period

Mereo BioPharma Group PLC ADR Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
-
-
-
1
-
0
-
-
-
Gross Profit
1
0
0
0
0
0
0
0
0
0
Operating Income
-7
-9
-12
-9
-15
-11
-10
-10
-8
-8
EBITDA
-9
-8
-11
-14
-6
-12
-14
-9
-6
-8
Interest Expense
4
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-9
-8
-12
-15
-7
-12
-14
-7
-7
-6
Income Tax Expense
0
0
0
-15
0
-
-
-
0
0
Net Income
-9
-8
-12
-15
-6
-12
-14
-7
-7
-6
Net Profit Margin
-910.90%
0.00%
0.00%
0.00%
-655.92%
0.00%
-2923.20%
0.00%
0.00%
0.00%

Mereo BioPharma Group PLC ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-4
-
0
0
65
1
10
-
0
Gross Profit
-30
-50
-28
-2
-2
33
0
7
-1
0
Operating Income
-36
-45
-35
-50
-48
-28
-53
-28
-47
-38
EBITDA
-38
-44
-34
-44
-203
25
-39
-26
-40
-40
Interest Expense
0
1
2
3
6
5
3
2
1
0
Depreciation
-
0
0
1
1
0
0
1
1
1
Income Before Tax
-33
-46
-37
-52
-213
19
-44
-29
-43
-41
Income Tax Expense
-5
-8
-5
-8
-3
2
-2
0
0
-1
Net Income
-35
-52
-40
-58
-281
22
-51
-29
-43
-41
Net Profit Margin
0.00%
1180.99%
0.00%
36435.94%
-53391.63%
34.90%
-2795.09%
-294.66%
0.00%
-8375.60%

Mereo BioPharma Group PLC ADR Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-8
-12
-14
-7
-12
-14
-7
-7
-6
Operating Cash Flow
-7
-7
-7
-9
-8
-7
-7
-7
-4
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
-
46
0
0
0
0
-
0
-
Change in Cash
-8
38
-6
-10
-7
-6
-7
-7
-4

Mereo BioPharma Group PLC ADR Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-46
-37
-53
-226
19
-42
-29
-43
-41
Operating Cash Flow
-32
-23
-60
-38
-7
-48
-21
-32
-30
Investing Cash Flow
-3
0
56
2
0
1
0
0
0
Financing Cash Flow
33
-2
-7
47
104
0
7
46
0
Change in Cash
-3
-25
-11
9
95
-59
-10
12
-28

Global Institutional Holdings in Mereo BioPharma Group PLC ADR

Funds
Holdings
Jane Street Group LLC
0.22%
Tejara Capital Ltd
1.28%
BlackRock Inc
0.19%
HHG PLC
10.21%
Clearline Capital LP
2.27%
See all

Insights on Mereo BioPharma Group PLC ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MREO stock has moved up by 22.2%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -7.35M → -6.70M (in $), with an average increase of 9.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Mereo BioPharma Group plc American Depositary Shares has experienced a drawdown of -77.1%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 59.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.1% return, outperforming this stock by 106.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.06M → 500.0K (in $), with an average decrease of 53.0% per quarter

About Mereo BioPharma Group PLC ADR

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency associated lung disease; and Vantictumab, an anti-FZD monoclonal antibody for the treatment of autosomal dominant osteopetrosis type 2. It also develops Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism; Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Etigilimab, an IgG1 monoclonal antibody which binds to the human TIGIT receptor on immune cells for the Treatment of advanced solid tumors; and Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.
OrganisationMereo BioPharma Group PLC ADR
HeadquartersOne Cavendish Place, London, United Kingdom, W1G 0QF
IndustryBiotechnology
CEODr. Denise Vera Scots-Knight Ph.D.
E-voting on sharesClick here to vote

Key Management of Mereo BioPharma Group PLC ADR

Name

Title

Mr. Charles Edward Sermon

Co-Founder, General Counsel, Business Development & Company Secretary

Dr. John A. Lewicki Ph.D.

Chief Scientific Officer

Ms. Alexandra Hughes-Wilson

Chief of Patient Access & Commercial Planning

Mr. Bo Kara

Senior VP and Head of Pharmaceutical Development & CMC

Dr. Denise Vera Scots-Knight Ph.D.

Co-Founder, CEO & Executive Director

Ms. Bal Lally

VP & Head of HR

Dr. Jackie Parkin

Senior VP & Therapeutic Head

Ms. Bharti Navsariwala

VP & Head of Regulatory Affairs

Dr. Ogun Sazova

VP & Head of Medical Affairs

Ms. Christine Fox CPA

Chief Financial Officer

FAQs

What is Mereo BioPharma Group PLC ADR share price today?

Mereo BioPharma Group PLC ADR share price today is $0.3 as on at the close of the market. Mereo BioPharma Group PLC ADR share today touched a day high of $0.31 and a low of $0.29.

What is the 52 week high and 52 week low for Mereo BioPharma Group PLC ADR share?

Mereo BioPharma Group PLC ADR share touched a 52 week high of $3.05 on and a 52 week low of $0.2 on . Mereo BioPharma Group PLC ADR stock price today i.e. is closed at $0.3,which is 90.16% down from its 52 week high and 50.00% up from its 52 week low.

What is Mereo BioPharma Group PLC ADR's market capitalisation today?

Mereo BioPharma Group PLC ADR market capitalisation is $0.00T as on .

How to invest in Mereo BioPharma Group PLC ADR Stock (MREO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mereo BioPharma Group PLC ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mereo BioPharma Group PLC ADR Shares that will get you 5.0000 shares as per Mereo BioPharma Group PLC ADR share price of $0.3 per share as on June 10, 2026 at 1:28 am IST.

What is the minimum amount required to buy Mereo BioPharma Group PLC ADR Stock (MREO) from India?

Indian investors can start investing in Mereo BioPharma Group PLC ADR (MREO) shares with as little as ₹95.34 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.40 in Mereo BioPharma Group PLC ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Mereo BioPharma Group PLC ADR share’s latest price of $0.3 as on June 10, 2026 at 1:28 am IST, you will get 33.3333 shares of Mereo BioPharma Group PLC ADR. Learn more about fractional shares .

What are the returns that Mereo BioPharma Group PLC ADR has given to Indian investors in the last 5 years?

Mereo BioPharma Group PLC ADR stock has given -90.44% share price returns and 31.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?